Your browser doesn't support javascript.
loading
Sclerosing mesenteritis following immune checkpoint inhibitor therapy.
Kuang, Andrew G; Sperling, Gabriel; Liang, Tom Z; Lu, Yang; Tan, Dongfeng; Bollin, Kathryn; Johnson, Douglas B; Manzano, Joanna-Grace M; Shatila, Malek; Thomas, Anusha S; Thompson, John A; Zhang, Hao Chi; Wang, Yinghong.
Afiliación
  • Kuang AG; Department of Medicine, Baylor College of Medicine, Houston, TX, USA.
  • Sperling G; The University of Texas Medical Branch John Sealy School of Medicine, Galveston, TX, USA.
  • Liang TZ; Division of Pathology/Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Lu Y; Department of Nuclear Medicine, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Tan D; Division of Pathology/Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Bollin K; Division of Hematology and Oncology, Scripps MD Anderson Cancer Center, La Jolla, CA, USA.
  • Johnson DB; Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Manzano JM; Department of Hospital Medicine, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Shatila M; Department of Gastroenterology, Hepatology, & Nutrition, Division of Internal Medicine, Unit 1466, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA.
  • Thomas AS; Department of Gastroenterology, Hepatology, & Nutrition, Division of Internal Medicine, Unit 1466, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA.
  • Thompson JA; Divison of Medical Oncology, University of Washington, Seattle, WA, USA.
  • Zhang HC; Department of Gastroenterology, Hepatology, & Nutrition, Division of Internal Medicine, Unit 1466, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA.
  • Wang Y; Department of Gastroenterology, Hepatology, & Nutrition, Division of Internal Medicine, Unit 1466, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA. ywang59@mdanderson.org.
J Cancer Res Clin Oncol ; 149(11): 9221-9227, 2023 Sep.
Article en En | MEDLINE | ID: mdl-37195298
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Esclerosis / Inhibidores de Puntos de Control Inmunológico / Mediastinitis / Neoplasias Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Cancer Res Clin Oncol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Esclerosis / Inhibidores de Puntos de Control Inmunológico / Mediastinitis / Neoplasias Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Cancer Res Clin Oncol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos